Equifax's strong track record of surpassing consensus estimates underpins the 83.5% market-implied probability of a Q3 2026 earnings beat. The company delivered a 5.6% EPS beat and 11% revenue growth in Q2, with USIS revenue rising 17% and mortgage volumes contributing meaningfully despite higher rates. Analyst EPS consensus for the quarter ending September 30 sits near $2.22–$2.29 against company guidance of $2.15–$2.25, while revenue estimates cluster around $1.70 billion. Traders appear to price in continued execution momentum from diversified markets and prior outperformance patterns, with the October 20 release serving as the immediate catalyst that could confirm or challenge the current positioning.